Media Room



Latest News Releases
Jan 5, 2017

Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming 35th Annual J.P. Morgan Healthcare Conference in San Francisco...

Nov 14, 2016

Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its corporate presentation at the Jefferies 2016 London Healthcare Conference to be held at the Waldorf...

Nov 9, 2016

Nektar Therapeutics (Nasdaq: NKTR) today announced that new Phase 1 clinical data for Nektar's lead immuno-oncology agent, NKTR-214, were presented at the SITC 2016 Annual Meeting. NKTR-214 is an...

More »

Multimedia Libraries
Media Contacts
Dan Budwick
Pure Communications, Inc.

More »

Follow Us on LinkedIn
Follow Us on Twitter

print email
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide